July 2015

Trivitron Healthcare has added two new products in the newborn screening kit for India. The two new tests are Neonatal IRT and Neonatal Toxoplasma gondii IgM that detect disorders which may harm the newborn in later stages of life. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. Whereas, Neonatal Toxoplasma gondii IgM can detect neurological and visual disabilities.

Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.

Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.

Bosch, a leading global supplier of technology and services, has got the Zinnov Awards for its Eyecare device that was adjudged as an innovation with a potential to solve large scale global problems.

(NewsVoir); Randstad, one of the country’s leading HR service providers, today launched an exclusive ‘Talent Trends Report – HR Game Changers’ at the 12th edition of the NASSCOM HR Summit, held in Chennai. The report offers an overview of the top 15 workplace trends that will shape talent management in 2015 and beyond.

(Business Wire India); Apollo Children’s Hospital has once again showcased its expertise and technical know-how on implementing some of the latest technologies for the benefit of patients. Surgeries performed at the Children’s Hospital using the da Vinci robot provides patients with all the advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.